|
1
|
Spatz ES, Beckman AL, Wang Y, Desai NR and
Krumholz HM: Geographic variation in trends and disparities in
acute myocardial infarction hospitalization and mortality by income
levels, 1999–2013. JAMA Cardiol. 1:255–265. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reinstadler SJ, Baum A, Rommel KP, Eitel
C, Desch S, Mende M, Metzler B, Poess J, Thiele H and Eitel I:
ST-segment depression resolution predicts infarct size and
reperfusion injury in ST-elevation myocardial infarction. Heart.
101:1819–1825. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pellaton C, Cayla G, Silvain J, Zeymer U,
Cohen M, Goldstein P, Huber K, Pollack C Jr, Kerneis M, Collet JP,
et al: Incidence and consequence of major bleeding in primary
percutaneous intervention for ST-elevation myocardial infarction in
the era of radial access: An analysis of the international
randomized acute myocardial infarction treated with primary
angioplasty and intravenous enoxaparin or unfractionated heparin to
lower ischemic and bleeding events at short- and long-term
follow-up trial. Am Heart J. 170:778–786. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lemkes J, Nijveldt R, Beek AM, Knaapen P,
Hirsch A, Meijers J, Allaart CP, van Rossum A and van Royen N:
Evaluating the optimal timing of revascularisation in patients with
transient ST-segment elevation myocardial infarction: Rationale and
design of the TRANSIENT trial. J Cardiovasc Transl Res. 7:590–596.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alestalo K, Miettinen JA, Vuolteenaho O,
Huikuri H and Lehenkari P: Bone marrow mononuclear cell
transplantation restores inflammatory balance of cytokines after ST
segment elevation myocardial infarction. PLoS One. 10:e01450942015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aydin MU, Aygul N, Altunkeser BB, Unlu A
and Taner A: Comparative effects of high-dose atorvastatin versus
moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and
inflammatory markers in ST elevation myocardial infarction.
Atherosclerosis. 239:439–443. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bashar T and Akhter N: Study on oxidative
stress and antioxidant level in patients of acute myocardial
infarction before and after regular treatment. Bangladesh Med Res
Counc Bull. 40:79–84. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kitano D, Takayama T, Nagashima K, Akabane
M, Okubo K, Hiro T and Hirayama A: A comparative study of
time-specific oxidative stress after acute myocardial infarction in
patients with and without diabetes mellitus. BMC Cardiovasc Disord.
16:1022016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ibarra-Lara Mde L, Sánchez-Aguilar M,
Soria E, Torres-Narváez JC, Del Valle-Mondragón L, Cervantes-Pérez
LG, Pérez-Severiano F, Ramírez-Ortega Mdel C, Pastelín-Hernández G,
Oidor-Chan VH and Sánchez-Mendoza A: Peroxisome
proliferator-activated receptors (PPAR) downregulate the expression
of pro-inflammatory molecules in an experimental model of
myocardial infarction. Can J Physiol Pharmacol. 94:634–642. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lima Ede A, Lima MM, Marques CD, Duarte
AL, Pita Ida R and Pita MG: Peroxisome proliferator-activated
receptor agonists (PPARs): A promising prospect in the treatment of
psoriasis and psoriatic arthritis. An Bras Dermatol. 88:1029–1035.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lincoff AM, Tardif JC, Neal B, Nicholls
SJ, Rydén L, Schwartz GG, Malmberg K, Buse JB, Henry RR, Wedel H,
et al: Evaluation of the dual peroxisome proliferator-activated
receptor α/γ agonist aleglitazar to reduce cardiovascular events in
patients with acute coronary syndrome and type 2 diabetes mellitus:
Rationale and design of the AleCardio trial. Am Heart J.
166:429–434. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ata MA, Khand F, Shaikh SS and Ata MA:
Effect of smoking on serum xanthine oxidase and malondialdehyde
levels in patients with acute myocardial infarction. J Pak Med
Assoc. 65:39–42. 2015.PubMed/NCBI
|
|
13
|
Radhiga T, Rajamanickam C, Sundaresan A,
Ezhumalai M and Pugalendi KV: Effect of ursolic acid treatment on
apoptosis and DNA damage in isoproterenol-induced myocardial
infarction. Biochimie. 94:1135–1142. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jarr KU, Eschricht S, Burkly LC, Preusch
M, Katus HA, Frey N and Chorianopoulos E: TNF-like weak inducer of
apoptosis aggravates left ventricular dysfunction after myocardial
infarction in mice. Mediators Inflamm. 2014:1319502014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang H, Wang Z, Feng SJ, Xu L, Shi HX,
Chen LL, Yuan GD, Yan W, Zhuang W, Zhang YQ, et al: PEDF improves
cardiac function in rats with acute myocardial infarction via
inhibiting vascular permeability and cardiomyocyte apoptosis. Int J
Mol Sci. 16:5618–5634. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ning Y, Li Z and Qiu Z: FOXO1 silence
aggravates oxidative stress-promoted apoptosis in cardiomyocytes by
reducing autophagy. J Toxicol Sci. 40:637–645. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hofma SH, Smits PC, Brouwer J, Velders MA,
van't Hof AW, Queré M, de Vries CJ and van Boven AJ: Long-term
follow-up of second-generation everolimus-eluting stents versus
first-generation sirolimus-eluting stents in acute myocardial
infarction: Three-year results of the XAMI trial. EuroIntervention.
10:1280–1283. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Magro M, Raber L, Heg D, Taniwaki M,
Kelbaek H, Ostojić M, Baumbach A, Tüller D, von Birgelen C, Roffi
M, et al: The MI SYNTAX score for risk stratification in patients
undergoing primary percutaneous coronary intervention for treatment
of acute myocardial infarction: A substudy of the COMFORTABLE AMI
trial. Int J Cardiol. 175:314–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Padilla S, Masiá M, García N, Jarrin I,
Tormo C and Gutiérrez F: Early changes in inflammatory and
pro-thrombotic biomarkers in patients initiating antiretroviral
therapy with abacavir or tenofovir. BMC Infect Dis. 11:402011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ehrenpreis ED, Zhou Y, Alexoff A and
Melitas C: Effect of the diagnosis of inflammatory bowel disease on
risk-adjusted mortality in hospitalized patients with acute
myocardial infarction, congestive heart failure and pneumonia. PLoS
One. 11:e01589262016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Toldo S, Marchetti C, Mauro AG, Chojnacki
J, Mezzaroma E, Carbone S, Zhang S, Van Tassell B, Salloum FN and
Abbate A: Inhibition of the NLRP3 inflammasome limits the
inflammatory injury following myocardial ischemia-reperfusion in
the mouse. Int J Cardiol. 209:215–220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Prondzinsky R, Unverzagt S, Lemm H,
Wegener N, Heinroth K, Buerke U, Fiedler M, Thiery J, Haerting J,
Werdan K and Buerke M: Acute myocardial infarction and cardiogenic
shock: Prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF,
and MCP-1β. Med Klin Intensivmed Notfmed. 107:476–484. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Davies NM, Smith GD, Windmeijer F and
Martin RM: COX-2 selective nonsteroidal anti-inflammatory drugs and
risk of gastrointestinal tract complications and myocardial
infarction: An instrumental variable analysis. Epidemiology.
24:352–362. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rotimi SO, Bankole GE, Adelani IB and
Rotimi OA: Hesperidin prevents lipopolysaccharide-induced
endotoxicity in rats. Immunopharmacol Immunotoxicol. 38:364–371.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stamboul K, Lorin J, Lorgis L, Guenancia
C, Beer JC, Touzery C, Rochette L, Vergely C, Cottin Y and Zeller
M: Atrial fibrillation is associated with a marker of endothelial
function and oxidative stress in patients with acute myocardial
infarction. PLoS One. 10:e01314392015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang G, Zhu J, Zhou Y, Wei Y, Xi L, Qin
H, Rao Z, Han M, Ma Y and Wu X: Hesperidin alleviates oxidative
stress and upregulates the multidrug resistance protein 2 in
isoniazid and rifampicin-induced liver injury in rats. J Biochem
Mol Toxicol. 30:342–349. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Aonuma T, Takehara N, Maruyama K, Kabara
M, Matsuki M, Yamauchi A, Kawabe J and Hasebe N:
Apoptosis-resistant cardiac progenitor cells modified with
apurinic/apyrimidinic endonuclease/redox factor 1 gene
overexpression regulate cardiac repair after myocardial infarction.
Stem Cells Transl Med. 5:1067–1078. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tseng CY, Wang JS, Chang YJ, Chang JF and
Chao MW: Exposure to high-dose diesel exhaust particles induces
intracellular oxidative stress and causes endothelial apoptosis in
cultured in vitro capillary tube cells. Cardiovasc Toxicol.
15:345–354. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Siddiqi A, Nafees S, Rashid S, Sultana S
and Saidullah B: Hesperidin ameliorates trichloroethylene-induced
nephrotoxicity by abrogation of oxidative stress and apoptosis in
wistar rats. Mol Cell Biochem. 406:9–20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thenmozhi Justin A, William Raja TR,
Manivasagam T, Janakiraman U and Mohamed Essa M: Hesperidin
ameliorates cognitive dysfunction, oxidative stress and apoptosis
against aluminium chloride induced rat model of Alzheimer's
disease. Nutr Neurosci. 20:360–368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu Y, Zhang ZH, Wei SG, Weiss RM and
Felder RB: Peroxisome proliferator-activated receptor-γ regulates
inflammation and renin-angiotensin system activity in the
hypothalamic paraventricular nucleus and ameliorates peripheral
manifestations of heart failure. Hypertension. 59:477–484. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yasuda S, Kobayashi H, Iwasa M, Kawamura
I, Sumi S, Narentuoya B, Yamaki T, Ushikoshi H, Nishigaki K,
Nagashima K, et al: Antidiabetic drug pioglitazone protects the
heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and
eNOS pathway in a rabbit model of myocardial infarction. Am J
Physiol Heart Circ Physiol. 296:H1558–H1565. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kuo MY, Ou HC, Lee WJ, Kuo WW, Hwang LL,
Song TY, Huang CY, Chiu TH, Tsai KL, Tsai CS and Sheu WH: Ellagic
acid inhibits oxidized low-density lipoprotein (OxLDL)-induced
metalloproteinase (MMP) expression by modulating the protein kinase
C-α/extracellular signal-regulated kinase/peroxisome
proliferator-activated receptor γ/nuclear factor-κB
(PKC-α/ERK/PPAR-γ/NF-κB) signaling pathway in endothelial cells. J
Agric Food Chem. 59:5100–5108. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Agrawal YO, Sharma PK, Shrivastava B, Ojha
S, Upadhya HM, Arya DS and Goyal SN: Hesperidin produces
cardioprotective activity via PPAR-γ pathway in ischemic heart
disease model in diabetic rats. PLoS One. 9:e1112122014. View Article : Google Scholar : PubMed/NCBI
|
